Obesity, lipids, and glucose intolerance. The Framingham Study

Area of Science:

• Cardiovascular Health
• Metabolic Syndrome
• Obesity Research

Background:

• Obesity is a growing public health concern.
• Understanding its association with metabolic disturbances like glucose intolerance is crucial.
• Lipid and lipoprotein profiles are key indicators of metabolic health.

Purpose of the Study:

• To examine lipid and lipoprotein profiles in relation to obesity.
• To investigate the association between obesity and glucose intolerance.
• To analyze these relationships across different age groups and sexes.

Main Methods:

• Analysis of the Framingham cohort data.
• Inclusion of 5209 men and women aged 30-59.
• Biennial examinations over an 18-year period.

Main Results:

• Beta and pre-beta lipoproteins positively correlated with relative weight.
• High-density lipoprotein cholesterol inversely correlated with relative weight, strongest association observed.
• Triglycerides also correlated with obesity, with stronger associations in men and younger individuals.
• Obese individuals showed higher likelihood of glycosuria and increased diabetes prevalence.
• Cohort analysis revealed increasing relative weight in men and shifting weight trends in women over time.

Conclusions:

• Obesity is significantly associated with adverse lipid profiles and increased risk of glucose intolerance and diabetes.
• High-density lipoprotein cholesterol is a key lipid marker inversely related to obesity.
• Longitudinal data highlight persistent weight trends and associated metabolic risks across demographics.